Navidea Biopharmaceuticals to Announce Fourth Quarter and Full Year 2015 Results on March 23, 2016

Mar 21, 2016

Navidea Biopharmaceuticals Announces Delay in Filing of Form 10-K

Mar 14, 2016

Navidea and Platinum Enter Into Agreement Reaffirming Loan Obligations and Agreeing to Standstill Provisions

Mar 14, 2016

Immunotherapeutic Potential of Manocept™ Platform Reviewed in the Journal Nuclear Medicine and Biology

Mar 10, 2016

Navidea Biopharmaceuticals Enrolls First Patient in Cervical Cancer Study of Lymphoseek®

Feb 11, 2016

Navidea Biopharmaceuticals to Present at 2016 BIO CEO & Investor Conference

Feb 4, 2016

Navidea Provides Update on Lymphoseek® and Immunodiagnostics Development Pipeline

Feb 2, 2016

Navidea Meets Guidance With 2015 Unaudited Lymphoseek® Sales of $10.2 Million

Jan 11, 2016

Navidea Appoints Anton Gueth Chairman of the Board

Jan 11, 2016

Navidea Biopharmaceuticals Enrolls First Patient in Pediatric Trial of Lymphoseek®

Jan 6, 2016